Nuvisan receives US$25 million grant to advance novel non-hormonal contraceptive drug discovery
Nuvisan ICB GmbH, a fully integrated contract research organisation providing drug discovery and development services (“Nuvisan”), is pleased to announce it has received a US$25 million grant from the Gates Foundation to advance a portfolio of novel…